Stay at home guidance for people with a cough during the pandemic could fuel 2,500 additional lung cancer deaths, a charity has warned.
The UK Lung Cancer Coalition (UKLCC) said improvements in survival that were occurring before Covid-19 are now in “jeopardy” unless urgent action is taken.
It estimates that delays in diagnosis caused by Covid-19 lockdowns and restrictions may result in a drop of up to 5.3 per cent in five-year survival in England.
The proportion of people living at least five years could drop from 17.6 per cent (for patients diagnosed 2014 to 2018) to around 12.3 per cent for those diagnosed during the pandemic, it said.
The coalition warned this may lead to more than 2,500 extra deaths in the UK.
It comes after official data revealed the number of people dying at home is now the highest since the turn of the century, with 21,471 excess deaths occurring in private homes between January and June this year.
Professor Robert Rintoul, chair of the UKLCC’s clinical advisory group, said: “Prior to the pandemic, real progress was being made in raising five-year survival rates.
“But Covid-19 has had a devastating impact on early diagnosis of lung cancer and has compromised our target of driving up five-year UK survival to 25 per cent by 2025.
“Lung cancer patients have been disproportionately affected by the pandemic.
“Government guidance to stay at home with a cough, reluctance to engage with healthcare services during lockdown, and pressures on already over-burdened health services have inevitably resulted in a fall in referrals and increase in late-stage presentations of the disease.
“We need to take urgent action to get back on track.”